Document Detail


Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system.
MedLine Citation:
PMID:  18797248     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cannabinoids, which are the active compounds of marijuana, produce some pharmacological effects similar to the opioids. In addition, there are functional interactions between the cannabinoid and opioid systems. In this study, we investigated the effects of intraperitoneal (i.p.) injection of opioid drugs on responses induced by intracentral amygdala (intra-CeA) microinjection of cannabinoid CB1 receptor agents in rats, using the elevated plus maze test of anxiety. I.p. injection of morphine (6 and 9 mg/kg) 30 min before testing, increased the percentage open arm time (%OAT) and the percentage open arm entries (%OAE), but not locomotor activity, showing an anxiolytic-like response. I.p. administration of the opioid receptor antagonist, naloxone (1 mg/kg) 15 min before testing, significantly reduced %OAT, but not %OAE and locomotor activity. The drug, however, tended to decrease locomotor activity. Intra-CeA administration of arachidonylcyclopropylamide (ACPA, an agonist shown to selectively activate CB1 receptors; 1.25 and 5 ng/rat) increased %OAT and %OAE but not locomotor activity, indicating an anxiolytic-like response. Coadministration of morphine (6 mg/kg, i.p.) plus ACPA (0.125 ng/rat, intra-CeA) increased the anxiolytic-like response. Administration of naloxone reversed the effects of intra-CeA injection of ACPA. Intra-CeA administration of the cannabinoid CB1 receptor antagonist, AM251 (2.5, 25, and 100 ng/rat) did not alter %OAT and %OAE, but the higher doses of the drug (25 and 100 ng/rat) reduced locomotor activity. Coadministration of morphine (6 mg/kg) or naloxone (0.1 mg/kg) with AM251 showed an anxiolytic-like response. In conclusion, the results may indicate an anxiolytic-like effect for cannabinoid CB1 receptors of the CeA and the existence of an interaction between the cannabinoid and the opioid systems in the modulation of anxiety.
Authors:
Mohammad-Reza Zarrindast; Shadi Sarahroodi; Ardeshir Arzi; Mohammad Javad Khodayar; Saba Taheri-Shalmani; Ameneh Rezayof
Related Documents :
2999838 - Effect of (asu1,7)e-ct, synthetic analogue of eel-calcitonin, on nociceptive transmission.
18981588 - Intracisternal, but not intrathecal, injection of naloxone inhibits cutaneous itch-rela...
1295718 - Mechanisms of adrenaline-induced antinociception in mice.
2342228 - Dual action mechanisms of kk-3, a newly synthesized leu-enkephalin derivative, in the p...
16442368 - Comparison of efficacy and safety of rosuvastatin versus atorvastatin in african-americ...
6618998 - Effect of (+)-gossypol on fertility in male hamsters.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Behavioural pharmacology     Volume:  19     ISSN:  0955-8810     ISO Abbreviation:  Behav Pharmacol     Publication Date:  2008 Oct 
Date Detail:
Created Date:  2008-09-19     Completed Date:  2009-01-23     Revised Date:  2009-07-07    
Medline Journal Info:
Nlm Unique ID:  9013016     Medline TA:  Behav Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  716-23     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, School of Medicine and Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran. zarinmr@ams.ac.ir
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amygdala / drug effects,  physiopathology*
Animals
Anxiety / physiopathology*
Arachidonic Acids / pharmacology
Arousal / drug effects,  physiology*
Fear / drug effects,  physiology
Male
Maze Learning / drug effects,  physiology
Morphine / pharmacology
Motor Activity / drug effects,  physiology
Naloxone / pharmacology
Narcotic Antagonists / pharmacology
Rats
Rats, Wistar
Receptor, Cannabinoid, CB1 / drug effects,  physiology*
Receptors, Opioid / drug effects,  physiology*
Chemical
Reg. No./Substance:
0/Arachidonic Acids; 0/Narcotic Antagonists; 0/Receptor, Cannabinoid, CB1; 0/Receptors, Opioid; 0/arachidonylcyclopropylamide; 465-65-6/Naloxone; 57-27-2/Morphine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Influence of chronic mild stress on the behavioural effects of acute tryptophan depletion induced by...
Next Document:  Therapeutically relevant plasma concentrations of memantine produce significant L-N-methyl-D-asparta...